Trump Picks Anti-Abortion Doctor Heidi Overton to Lead FDA

President Donald Trump has selected Dr. Heidi Overton

President Donald Trump has selected Dr. Heidi Overton, a physician known for her opposition to abortion and her presence beside him during false claims about vaccines, to serve as the next commissioner of the U.S. Food and Drug Administration. The announcement came via a post on Truth Social on Wednesday, where Trump praised Overton as a "ROCKSTAR" in his administration, citing her collaboration with Secretary Kennedy, Dr. Oz, and their team on what he called the "MOST TRANSFORMATIVE Health Agenda in History." He described her as someone who tackles the toughest challenges and delivers solutions that serve the country's best interests.

Overton, who holds both an M.D. and a Ph.D., has been vocal about her stance on reproductive health, previously stating that Congress should impose strict regulations on the abortion drug mifepristone, arguing that such measures are necessary "to protect women and children." Her nomination signals a potential shift in FDA policies regarding medication abortion, a topic that has drawn significant political and legal debate.

The pick has already generated reactions from both supporters and critics. Advocacy groups for reproductive rights have expressed concern over Overton's appointment, fearing that her views could influence FDA decisions on drug approvals and safety regulations. Meanwhile, conservative and anti-abortion organizations have welcomed the choice, viewing it as a step toward more stringent oversight of abortion-related medications.

If confirmed by the Senate, Overton would oversee

If confirmed by the Senate, Overton would oversee the FDA's vast responsibilities, including drug approvals, food safety, and medical device regulation. Her background in both clinical practice and research could bring a scientific perspective, but her ideological positions are likely to be a focal point during confirmation hearings.

The nomination is part of a broader pattern of Trump appointing figures who align with his health policy vision, which has included controversial statements on vaccines and public health measures. Overton's previous appearance alongside Trump during vaccine-related remarks has drawn scrutiny, as she did not correct his false assertions, raising questions about her commitment to evidence-based communication.

As the process moves forward, the Senate will evaluate Overton's qualifications and her potential impact on the FDA's mission. The outcome remains uncertain, but her nomination underscores the ongoing polarization around health issues in American politics.